|
|
 |
|
Viewing report
|
|
|
|
Company Financials: Amylin Pharmaceuticals, Inc.
Datamonitor, Jan 2010
The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .
Scope
- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation
- Provides key ratios
- Includes information on revenue distribution by business segments and geographies
Highlights of this title
Amylin Pharmaceuticals (Amylin) is engaged in the discovery, development and commercialization of potential drug candidates for the treatment of diabetes and obesity. It has two marketed products in its portfolio, namely, Byetta and Symlin, for the treatment of diabetes.The company is headquartered in San Diego, California.
Key reasons to purchase this title
- Access important financial information and analysis on the company in a single datapack
- Understand the financial evolution of the company over the last five years
- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization
Customers who bought this item also bought
Company Financials: Keryx Biopharmaceuticals, Inc.
Company Financials: Idenix Pharmaceuticals, Inc.
Company Financials: DUSA Pharmaceuticals, Inc.
Company Financials: Inspire Pharmaceuticals
Company Financials: Oncogenex Pharmaceuticals, Inc.
Company Financials: ISTA Pharmaceuticals, Inc.
Company Financials: Alexza Pharmaceuticals
Company Financials: POZEN, Inc.
Company Financials: Regeneron Pharmaceuticals, Inc.
Company Financials: Isis Pharmaceuticals, Inc.
|
|
|
|
